2019
DOI: 10.1615/critrevimmunol.2019030480
|View full text |Cite
|
Sign up to set email alerts
|

TAOK3, a Regulator of LCK–SHP-1 Crosstalk during TCR Signaling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Conversely, CD45+ cells from the brain exhibited enriched T cell gene signatures. These included higher expression of transcripts associated with the T cell receptor α constant gene (TRAC), genes involved in TCR signaling (TAOK3, Sos1) (17) (18), genes regulating T cell metabolism (ERN1 and TXNIP (19), and genes linked to effector and central memory T cell programs (HSP70, DNAJB1, HSPH1, GZMA, NKG7, ID2, HELIOS (encoded by IKZF2), homeobox only protein (HOPX), and IL-7R (20) (21) (22). Additionally, the expression of the trafficking factor ITGβ2 suggested LFA-1 mediated T cell migration across the blood-brain barrier.…”
Section: Single-cell Transcriptomic Analysis Of Cd45+ Leukocytes Iden...mentioning
confidence: 99%
“…Conversely, CD45+ cells from the brain exhibited enriched T cell gene signatures. These included higher expression of transcripts associated with the T cell receptor α constant gene (TRAC), genes involved in TCR signaling (TAOK3, Sos1) (17) (18), genes regulating T cell metabolism (ERN1 and TXNIP (19), and genes linked to effector and central memory T cell programs (HSP70, DNAJB1, HSPH1, GZMA, NKG7, ID2, HELIOS (encoded by IKZF2), homeobox only protein (HOPX), and IL-7R (20) (21) (22). Additionally, the expression of the trafficking factor ITGβ2 suggested LFA-1 mediated T cell migration across the blood-brain barrier.…”
Section: Single-cell Transcriptomic Analysis Of Cd45+ Leukocytes Iden...mentioning
confidence: 99%
“…Despite its relative novelty being comparable to similarly scored MAP3K16 and MAP3K17, TAOK3 is not an IDGeligible kinase. Existing literature identifies TAOK3 as a contributing regulator of osteoblast differentiation and skeletal mineralization, lipid partitioning in the liver, and t-cell receptor signaling [136][137][138][139]. Furthermore, TAOK3 has also been identified to regulate cancer stem-cells in pancreatic cancer and enhance microtubule-targeted drug resistance in breast cancer through NF-κB signaling [140,141].…”
Section: Map3k18 (Taok3)mentioning
confidence: 99%
“…Accordingly, both the gut microbiota and immune system are implicated in the etiopathogenesis or manifestation of NDDs (Fung et al, 2017). TAO kinases were reported to regulate immunity (Ormonde et al, 2018(Ormonde et al, , 2019Zhang et al, 2018), gut development (Huang et al, 2014) and likely in maintenance of microbiota integration since MAPKs are involved (Thomas and Versalovic, 2010). Thus, the possible non-neurological role of TAO kinases in NDDs should be seriously considered.…”
Section: Conclusion and Perspectivementioning
confidence: 99%